These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1210 related articles for article (PubMed ID: 32355963)
1. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease. Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963 [TBL] [Abstract][Full Text] [Related]
2. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2. Xia Y; Zhang G; Kou L; Yin S; Han C; Hu J; Wan F; Sun Y; Wu J; Li Y; Huang J; Xiong N; Zhang Z; Wang T Brain; 2021 Aug; 144(7):2024-2037. PubMed ID: 33792662 [TBL] [Abstract][Full Text] [Related]
3. Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1. Li Y; Wang Y; Kou L; Yin S; Chi X; Sun Y; Wu J; Jin Z; Zhou Q; Zou W; Wang T; Xia Y CNS Neurosci Ther; 2024 May; 30(5):e14738. PubMed ID: 38702933 [TBL] [Abstract][Full Text] [Related]
4. Microglia as modulators of exosomal alpha-synuclein transmission. Xia Y; Zhang G; Han C; Ma K; Guo X; Wan F; Kou L; Yin S; Liu L; Huang J; Xiong N; Wang T Cell Death Dis; 2019 Feb; 10(3):174. PubMed ID: 30787269 [TBL] [Abstract][Full Text] [Related]
5. Preferential microglial activation associated with pathological alpha synuclein transmission. Kim YE; Lai TT; Kim YJ; Jeon B J Clin Neurosci; 2020 Nov; 81():469-476. PubMed ID: 33222964 [TBL] [Abstract][Full Text] [Related]
6. TNFRSF10B is involved in motor dysfunction in Parkinson's disease by regulating exosomal α-synuclein secretion from microglia. Dai M; Yan L; Yu H; Chen C; Xie Y J Chem Neuroanat; 2023 Apr; 129():102249. PubMed ID: 36791922 [TBL] [Abstract][Full Text] [Related]
7. From inflammasome to Parkinson's disease: Does the NLRP3 inflammasome facilitate exosome secretion and exosomal alpha-synuclein transmission in Parkinson's disease? Si XL; Fang YJ; Li LF; Gu LY; Yin XZ; Jun-Tian ; Yan YP; Pu JL; Zhang BR Exp Neurol; 2021 Feb; 336():113525. PubMed ID: 33161049 [TBL] [Abstract][Full Text] [Related]
8. Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD. Chang C; Lang H; Geng N; Wang J; Li N; Wang X Neurosci Lett; 2013 Aug; 548():190-5. PubMed ID: 23792198 [TBL] [Abstract][Full Text] [Related]
9. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease. George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995 [TBL] [Abstract][Full Text] [Related]
10. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease. Fredlund F; Jimenez-Ferrer I; Grabert K; Belfiori LF; Luk K; Swanberg M J Parkinsons Dis; 2024; 14(4):693-711. PubMed ID: 38728204 [TBL] [Abstract][Full Text] [Related]
11. Exosomes from patients with Parkinson's disease are pathological in mice. Han C; Xiong N; Guo X; Huang J; Ma K; Liu L; Xia Y; Shen Y; Li J; Jiang H; Wang L; Guo S; Xu X; Zhang G; Liu J; Cao X; Zhang Z; Lin Z; Wang T J Mol Med (Berl); 2019 Sep; 97(9):1329-1344. PubMed ID: 31302715 [TBL] [Abstract][Full Text] [Related]
12. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease. Zheng T; Zhang Z Neurochem Int; 2021 Sep; 148():105094. PubMed ID: 34097990 [TBL] [Abstract][Full Text] [Related]
14. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein. Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327 [TBL] [Abstract][Full Text] [Related]
15. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein. Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536 [TBL] [Abstract][Full Text] [Related]
16. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments. Sanchez-Guajardo V; Tentillier N; Romero-Ramos M Neuroscience; 2015 Aug; 302():47-58. PubMed ID: 25684748 [TBL] [Abstract][Full Text] [Related]
17. α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters. Chistiakov DA; Chistiakov AA Acta Neurol Belg; 2017 Mar; 117(1):43-51. PubMed ID: 27473175 [TBL] [Abstract][Full Text] [Related]
18. Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson's disease. Olanow CW; Savolainen M; Chu Y; Halliday GM; Kordower JH Brain; 2019 Jun; 142(6):1690-1700. PubMed ID: 31056668 [TBL] [Abstract][Full Text] [Related]
19. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease. Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303 [TBL] [Abstract][Full Text] [Related]
20. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease. Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]